The Treatment of Myeloid Malignancies with Kinase Inhibitors, An Issue of Hematology/Oncology Clinics of North America

This issue of Hematology/Oncology Clinics will focus on The Treatment of Myeloid Malignancies with Kinase Inhibitors. Articles will focus on: Targeting aberrant signaling in myeloid malignancies: promise versus reality; The development and use of imatinib for the treatment of chronic myelogenous leukemia; Mechanisms of resistance to ABL kinase inhibition in CML and the development of next generation ABL kinase inhibitors; Tyrosine kinase inhibitors in the treatment of systemic mastocytosis and hypereosinophilic syndrome; The development and use of JAK2 inhibitors for the treatment of myeloproliferative neoplasms (MPN); Mechanisms of resistance to JAK2 inhibitors in MPN; Kinase inhibitor screening in myeloid malignancies; and more!

Produktdetails

• Autoren: Ann Mullally
• Verlag: Elsevier Health Science
• Sprache: Englisch
• Produktform: Fester Einband
• Erschienen: 25.09.2017
• EAN: 9780323532358
• ISBN: 978-0-323-53235-8
• Abmessung: 152 mm x 228 mm x 229 mm
• Gewicht: 410 g
• Serie: The Clinics: Internal Medicine
• Themen: Naturwissenschaften, Medizin, Informatik, Technik > Medizin > Klinische Fächer; MEDICAL / Hematology, MEDICAL / Reference, Oncology, Haematology, MEDICAL / Oncology / General